Loading clinical trials...
Loading clinical trials...
Performance of the Dexcom Continuous Glucose Monitoring (CGM) System in Pregnant Women With Diabetes Mellitus
Age
18 - No limit years
Sex
FEMALE
Healthy Volunteers
No
Sansum Diabetes Research Institute
Santa Barbara, California, United States
Barbara Davis Center for Childhood Diabetes
Aurora, Colorado, United States
Joslin Diabetes Center
Boston, Massachusetts, United States
Icahn School of Medicine at Mount Sinai
New York, New York, United States
Oregon Health & Science University
Portland, Oregon, United States
Start Date
July 8, 2021
Primary Completion Date
March 31, 2022
Completion Date
April 15, 2022
Last Updated
February 21, 2022
100
ESTIMATED participants
Dexcom CGM System
DEVICE
Lead Sponsor
DexCom, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07480161